C07D 295/104
With the ring nitrogen atoms and the doubly bound oxygen or sulfur
Official title: with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
C07D295/104 (With the ring nitrogen atoms and the doubly bound oxygen or sulfur) appears on 329 US grants and 282 published applications in this corpus.
Search patents in C07D- Granted patents
- 329
- Published applications
- 282
- Assignees
- 269
- Inventors
- 1,163
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 9 | 0 |
| 1983 | 3 | 0 |
| 1984 | 5 | 0 |
| 1985 | 9 | 0 |
| 1986 | 6 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 6 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 6 | 0 |
| 2001 | 3 | 2 |
| 2002 | 15 | 8 |
| 2003 | 7 | 19 |
| 2004 | 13 | 10 |
| 2005 | 4 | 11 |
| 2006 | 4 | 13 |
| 2007 | 5 | 11 |
| 2008 | 3 | 9 |
| 2009 | 7 | 9 |
| 2010 | 6 | 13 |
| 2011 | 6 | 12 |
| 2012 | 6 | 11 |
| 2013 | 12 | 4 |
| 2014 | 9 | 17 |
| 2015 | 11 | 12 |
| 2016 | 12 | 18 |
| 2017 | 20 | 18 |
| 2018 | 7 | 12 |
| 2019 | 7 | 12 |
| 2020 | 9 | 17 |
| 2021 | 12 | 7 |
| 2022 | 8 | 12 |
| 2023 | 9 | 7 |
| 2024 | 4 | 6 |
| 2025 | 1 | 8 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Process for the preparation of α-functionalized ketones9 Sep 2025US 12,410,114 B2Igm Group B. V.
- Inhibitors of the n-terminal domain of the androgen receptor10 Dec 2024US 12,162,818 B2The Regents of the University of California
- Cycloalkylurea derivative10 Dec 2024US 12,162,872 B2Sumitomo Pharma Co., Ltd.
- Oxime ester compound and photopolymerization initiator containing same18 Jun 2024US 12,013,637 B2Adeka Corporation
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Triazine compound salt, crystal form thereof, and production method therefor25 Jun 2026US 2026/0176240 A1Tanabe Pharma Corporation
- Compositions and methods for inducing ferroptosis5 Feb 2026US 2026/0034094 A1Kojin Therapeutics, Inc.
- Triazine compound salt, crystal form thereof, and production method therefor8 Jan 2026US 2026/0008756 A1Mitsubishi Tanabe Pharma Corporation
- Compositions and methods for the treatment of parkinson's and gaucher disease18 Dec 2025US 2025/0382274 A1
Most cited
By later US patents
- Acrylamido functional disubstituted acetyl aryl ketone photoinitiators213US 5,506,279 AMinnesota Mining and Manufacturing Company · 1996
- Sensitizers for photopolymerization190US 4,308,400 ACiba-Geigy Corporation · 1981
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Compounds with activity on muscarinic receptors147US 6,528,529 B1ACADIA Pharmaceuticals Inc. · 2003
- Use of aromatic-aliphatic ketones as photo sensitizers118US 4,318,791 ACiba-Geigy Corporation · 1982